Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 96 Triple Negative Breast Neoplasms 42 Breast Neoplasms, Male 18 Inflammatory Breast Neoplasms 11 Neoplasm Metastasis 8 Carcinoma, Non-Small-Cell Lung 7 Ovarian Neoplasms 6 Lung Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Stomach Neoplasms 4 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Esophageal Neoplasms 4 Endometrial Neoplasms 4 Anatomic Stage I Breast Cancer AJCC v8 4 Sarcoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Renal Cell 3 Urinary Bladder Neoplasms 2 Testicular Neoplasms 2 Small Cell Lung Carcinoma 2 Salivary Gland Neoplasms 2 Neoplasms, Unknown Primary 2 Neoplasms 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Breast Carcinoma In Situ 2 Anatomic Stage II Breast Cancer AJCC v8 2 Uterine Cervical Neoplasms 1 Thrombocytosis 1

Interventions

Fulvestrant 19 Letrozole 10 Anastrozole 8 Capecitabine 5 palbociclib 4 olaparib 4 Paclitaxel 4 Injections 4 Goserelin 4 Docetaxel 4 trastuzumab deruxtecan 3 pyrotinib 3 exemestane 3 Vinorelbine 3 Aromatase Inhibitors 3 toripalimab 2 sacituzumab govitecan 2 ribociclib 2 eribulin 2 elacestrant 2 dalpiciclib 2 abemaciclib 2 Trastuzumab 2 Gonadotropin-Releasing Hormone 2 FCN-437c 2 Everolimus 2 Dasatinib 2 Alpelisib 2 Albumin-Bound Paclitaxel 2 AZD9833 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Cancer × Taxes × Breast × Clear all

NCT04826016 2023-03-20

POLTER

MedSIR

Phase 1/2 Withdrawn

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡